Heres a list of GLP-1 agonists available on the market today: Semaglutide injection (Ozempic, Wegovy) Semaglutide tablets (Rybelsus) Liraglutide (Victoza, Saxenda) Tirzepatide (Mounjaro, Zepbound), which also enhances gastric inhibitory polypeptide (GIP), another incretin Dulaglutide (Trulicity) Exenatide (Byetta) Exenatide extended-release (Bydureon) Lixisenatide (Adlyxin) Several GLP-1 agonists are FDA-approved to manage type 2 diabetes and/or obesity, though the exact FDA-approved uses vary among the various products
As a novel antidiabetic agent, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are seeing an increasing application in the management of patients with T2DM, given their remarkable efficacy in regulating blood sugar levels without posing an elevated risk of hypoglycemic episodes or weight gain (Nauck, 2016)
The Natural GLP-1 Charmers: Berberine and Turmeric Now, lets turn the spotlight on some natural alternatives that have been around the block
Wegovy (semaglutide) injection, for subcutaneous use: prescribing information
It induces DNA damage, promotes oncogene activation, and modulates signaling pathways, thus enhancing tumor growth and metastasis [106,107]
Evaluation often includes: Comprehensive ophthalmologic exam with optic disc assessment Visual field testing Optical coherence tomography (OCT) to assess optic nerve head and retinal nerve fiber layer Blood pressure assessment and cardiovascular risk review Laboratory testing if giant cell arteritis is suspected (commonly ESR, CRP, platelet count), and possible temporal artery evaluation based on clinical presentation Treatment options for NAION are limited, and practice varies
